ACANTHAMOEBA KERATITIS
Clinical trials for ACANTHAMOEBA KERATITIS explained in plain language.
Never miss a new study
Get alerted when new ACANTHAMOEBA KERATITIS trials appear
Sign up with your email to follow new studies for ACANTHAMOEBA KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare eye parasite: study tests drug combo and steroid timing
Disease control CompletedThis study looked at the best way to treat acanthamoeba keratitis, a rare but serious eye infection. 49 participants first received either chlorhexidine alone or with povidone iodine, then were randomly assigned to early, late, or no steroids. The goal was to find which approach …
Matched conditions: ACANTHAMOEBA KERATITIS
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Light-Activated dye shows promise for tough eye infections
Disease control CompletedThis study tested whether adding a rose Bengal dye and green light treatment to standard antibiotic or antifungal eye drops could improve vision in people with severe corneal infections. 330 adults in India and Brazil with fungal, amoeba, or culture-negative ulcers and vision of …
Matched conditions: ACANTHAMOEBA KERATITIS
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for rare eye infection: eye drops show promise in study
Disease control CompletedThis study looked back at medical records of 40 people with a rare, serious eye infection called acanthamoeba keratitis. All patients received a special eye drop (0.8 mg/ml polihexanide) as part of a compassionate use program. The goal was to see how many patients were cured, mea…
Matched conditions: ACANTHAMOEBA KERATITIS
Sponsor: SIFI SpA • Aim: Disease control
Last updated May 13, 2026 16:03 UTC